- Home/
- Article /
- Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials.
Full Author : ['Sinha, Binayak', 'Ghosal, Samit']
Journal Title : Scientific reports
Chapter : Section17, Section2, Section4
Journal Year : 2020
Cited by : 20
The safety and usefulness of pioglitazone (Pio) is repeatedly called into question due to the contradictory information available about it. A meta-analysis and risk benefit assessment was conducted to address the various points of debate regarding Pio. El.....
Read More
Keywords : ['type diabete', 'prospective trial', 'treatment', 'risk', 'pioglitazone', 'patient', 'need', 'metaanalysis', 'benefit', 'assess']
PubMed Link : https://www.nature.com/articles/s41598-020-72967-8 Google Scholar Link : https://scholar.google.com/scholar?cites=7974106354501219798&as_sdt=2005&sciodt=0,5&hl=en&num=20